-
公开(公告)号:DK395789D0
公开(公告)日:1989-08-11
申请号:DK395789
申请日:1989-08-11
Applicant: HOECHST AG
Inventor: MOELLING KARIN , KLEEMANN HEINZ-WERNER , URBACH HANSJOERG , KOENIG WOLFGANG , RUPPERT DIETER , WINKLER IRVIN , PAESSENS ARNOLD
IPC: C12N9/99 , A61K31/69 , A61K38/00 , A61K38/55 , A61P31/12 , A61P43/00 , C07F5/02 , C07K5/04 , C07K14/81
Abstract: The invention relates to the use of compounds of the formula I in which A is a radical of the formulae A is absent or is a radical of the formula R , R and R are as defined in the description, and x and y are, independently of one another, -O- or -NR and to the salts thereof for the therapy and prophylaxis of viral diseases, especially diseases caused by HIV.
-
公开(公告)号:HUT47936A
公开(公告)日:1989-04-28
申请号:HU465088
申请日:1988-09-09
Applicant: HOECHST AG
Inventor: WINKELMANN ERHARDT , WINKLER IRVIN , MEICHSNER CHRISTOPH
IPC: A61K31/52 , A61K31/70 , A61K31/7042 , A61K31/7052 , A61K31/7076 , A61K31/715 , A61P31/12 , A61P35/00 , A61P37/04 , C07D473/38 , C07H19/16
Abstract: Medicines based on compounds of the formula I in which R is H, NH2 or acylamino, and R is a defined organic radical, are particularly suitable for controlling diseases caused by (DNA and RNA) viruses and for the treatment of autoimmune diseases and of cancer.
-
公开(公告)号:ZA886676B
公开(公告)日:1989-04-26
申请号:ZA886676
申请日:1988-09-08
Applicant: HOECHST AG
Inventor: WINKELMANN ERHARDT , ERHARDT WINKELMANN , WINKLER IRVIN , IRVIN WINKLER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER
IPC: A61K31/52 , A61K31/70 , A61K31/7042 , A61K31/7052 , A61K31/7076 , A61K31/715 , A61P31/12 , A61P35/00 , A61P37/04 , C07D473/38 , C07H19/16 , C07D , C07H , A61K
Abstract: Medicines based on compounds of the formula I in which R is H, NH2 or acylamino, and R is a defined organic radical, are particularly suitable for controlling diseases caused by (DNA and RNA) viruses and for the treatment of autoimmune diseases and of cancer.
-
公开(公告)号:ZA885577B
公开(公告)日:1989-04-26
申请号:ZA885577
申请日:1988-07-29
Applicant: HOECHST AG
Inventor: SCHRINNER ELMAR , ELMAR SCHRINNER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , WINKLER IRVIN , IRVIN WINKLER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER
IPC: C07D473/06 , A61K20060101 , A61K31/52 , A61K31/70 , A61K31/715 , A61P31/12 , C07D20060101 , C07D473/04 , C08B20060101 , C08B37/00 , A61K , C08B , C07D
Abstract: The preparation contains or consists of… a) at least one sulphated polysaccharide and… b) at least one xanthine derivative. The preparation is suitable for the control and prophylaxis of viral diseases, especially those caused by retroviruses.
-
公开(公告)号:DK453686D0
公开(公告)日:1986-09-23
申请号:DK453686
申请日:1986-09-23
Applicant: HOECHST AG
Inventor: WINKELMANN ERHARDT , ROLLY HEINRICH , WINKLER IRVIN
IPC: A61K31/52 , C07D473/00 , C07D
Abstract: Compounds of the formula 1 in which R is H, halogen, OH, SH, azido, NH2 or Z-R , where Z denotes O, S, SO, SO2 or NH and R denotes an acyclic aliphatic hydrocarbon radical having 1 to 6 C atoms, which a) is unsubstituted or b) is modified by at least one of the features that it contains an alkoxy group having 1 to 3 C atoms or a double bond or is at least partially fluorinated, or denotes cycloalkyl having 3 to 6 C atoms or phenylalkyl which is bonded directly to Z or via an alkylene group of 1 to 3 C atoms, or phenyl, where the phenyl ring can in each case be substituted at most twice, preferably at most once, by a substituent from the group halogen, trifluoromethyl, alkoxy and alkylthio each having 1 to 3 C atoms, R is H or has the meaning of R or is an acyl group CO-R , where R is alkyl having 1 to 6 C atoms, benzyl or phenyl, R denotes halogen, azido, unsubstituted amino or the radical Y-R , where R has the same meaning as R and Y, like X, denotes O, S, SO or SO2 and X and Y can be identical or different, where those compounds are excepted in which, at the same time, R is OH or SH, R is H, R is Y-R , X is O or S, Y is O and R is alkyl having 1 to 4 C atoms or in which, at the same time, R is OH or NH2, R is benzyl, R is Y-R where Y = O and R = benzyl and X is O, are used for the treatment of diseases caused by viruses.
-
公开(公告)号:PL196578B1
公开(公告)日:2008-01-31
申请号:PL32534398
申请日:1998-03-12
Applicant: HOECHST AG
Inventor: KIRSCHBAUM BERND , STAHL WILHELM , WINKLER IRVIN , MEISTERERNST MICHAEL
-
公开(公告)号:CA2087818C
公开(公告)日:2007-07-10
申请号:CA2087818
申请日:1993-01-21
Applicant: HOECHST AG
Inventor: UHLMANN EUGEN , PEYMAN ANUSCHIRWAN , O'MALLEY GERARD , HELSBERG MATTHIAS , WINKLER IRVIN
IPC: A61K31/70 , C07H21/00 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/22 , C07F9/24 , C07F9/48 , C07F9/553 , C07H1/00 , C07H21/04 , C12Q1/68
Abstract: The invention relates to compounds of the formula I (see formula I) where R1 is H, alkyl, acyl, aryl or a phosphate residue; R2 is H, OH, alkoxy, NH2 or halogen; B is a base customary in nucleotide chemistry; a is O or CH2; n is an integer from 1 to 100; W = O, S or Se; V = O, S or NH; Y = O, S, NH or CH2; Y' = O, S, NH or alkylene; X = OH or SH; U = OH, SH, SeH, alkyl, aryl or amine and Z = OH, SH, SeH, an optionally substituted radical from the group comprising alkyl, aryl, heteroaryl, alkoxy or amino, or a group which favors intracellular uptake or serves as the label of a DNA probe or attacks the target nucleic acid during hybridization, where if Z = OH, SH, CH3 or OC2H5, at least one of the groups X, Y, Y', V or W is not OH or O or R1 is not H; a process for their preparation and their use as inhibitors of gene expression, as probes for detecting nucleic acids and as aids in molecular biology.
-
公开(公告)号:DE59409894D1
公开(公告)日:2001-11-08
申请号:DE59409894
申请日:1994-02-25
Applicant: HOECHST AG
Inventor: BUDT KARL-HEINZ , STOWASSER BERND , PEYMAN ANUSCHIRWAN , KNOLLE JOCHEN , WINKLER IRVIN , BERSCHEID HANS-GERD
IPC: C07D295/08 , A61K31/215 , A61K31/22 , A61K31/27 , A61K31/40 , A61K31/415 , A61K31/4184 , A61K31/425 , A61K31/426 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4418 , A61K31/4427 , A61K31/47 , A61K31/535 , A61K31/5355 , A61K31/5375 , A61K31/66 , A61K38/00 , A61P31/12 , A61P37/00 , A61P43/00 , C07C317/44 , C07C323/52 , C07D207/16 , C07D213/40 , C07D215/48 , C07D235/14 , C07D277/04 , C07D401/12 , C07F9/53 , C07K5/02 , C07K7/02
Abstract: PCT No. PCT/EP94/00561 Sec. 371 Date Sep. 12, 1995 Sec. 102(e) Date Sep. 12, 1995 PCT Filed Feb. 25, 1994 PCT Pub. No. WO94/21604 PCT Pub. Date Sep. 29, 1994The invention concerns prodrugs of enzyme inhibitors in which at least one OH- group in the enzyme inhibitor has been converted into a derivative grouping of the formula III, IV or V: (III) (IV) (V) in which the groups R11 to R25 and s,l, m, o, q, and r are as defined in the description. Such prodrugs exhibit an improved solubility in water and improved pharmaco-kinetic characteristics.
-
公开(公告)号:AT206393T
公开(公告)日:2001-10-15
申请号:AT94909071
申请日:1994-02-25
Applicant: HOECHST AG
Inventor: BUDT KARL-HEINZ , STOWASSER BERND , PEYMAN ANUSCHIRWAN , KNOLLE JOCHEN , WINKLER IRVIN , BERSCHEID HANS-GERD
IPC: C07D295/08 , A61K31/215 , A61K31/22 , A61K31/27 , A61K31/40 , A61K31/415 , A61K31/4184 , A61K31/425 , A61K31/426 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4418 , A61K31/4427 , A61K31/47 , A61K31/535 , A61K31/5355 , A61K31/5375 , A61K31/66 , A61K38/00 , A61P31/12 , A61P37/00 , A61P43/00 , C07C317/44 , C07C323/52 , C07D207/16 , C07D213/40 , C07D215/48 , C07D235/14 , C07D277/04 , C07D401/12 , C07F9/53 , C07K5/02 , C07K7/02
Abstract: PCT No. PCT/EP94/00561 Sec. 371 Date Sep. 12, 1995 Sec. 102(e) Date Sep. 12, 1995 PCT Filed Feb. 25, 1994 PCT Pub. No. WO94/21604 PCT Pub. Date Sep. 29, 1994The invention concerns prodrugs of enzyme inhibitors in which at least one OH- group in the enzyme inhibitor has been converted into a derivative grouping of the formula III, IV or V: (III) (IV) (V) in which the groups R11 to R25 and s,l, m, o, q, and r are as defined in the description. Such prodrugs exhibit an improved solubility in water and improved pharmaco-kinetic characteristics.
-
40.
公开(公告)号:CA2231745A1
公开(公告)日:1998-09-12
申请号:CA2231745
申请日:1998-03-11
Applicant: HOECHST AG
Inventor: WINKLER IRVIN , MEISTERERNST MICHAEL , STAHL WILHELM , KIRSCHBAUM BERND
Abstract: The invention relates to an in-vitro process for analyzing transcription of vira l and cellular genes which can be automated and which is suitable for efficient and economical bulk screening with the aim of finding specific chemical lead structu res which have a selective effect on gene activity. The process for the cell-free in-vitro transcription of a DNA template comprisin g a DNA sequence to be transcribed which is under the control of at least one gene-regulatory element comprises a) using, for the transcription, a concentrated and, if appropriate, purified ex tract from cell nuclei which, if appropriate, can be complemented, or partially or ful ly replaced, by transcription factors and/or cofactors, and at least one labeled nucleotide, b) if appropriate isolating and/or degrading the proteins in the reaction mixtur e after transcription, c) binding the labeled transcript to a solid matrix, d) removing the excess labeled nucleotides and e) determining the amount of labeled transcript.
-
-
-
-
-
-
-
-
-